## Chunk 1 (pages 1-1)

## Key points
- List of participants and roles:
  - Peter McGregor — Marketing
  - John Gibbons — Corporate supply planning; manages supply planning (SOP); works with plants
  - Bill Miller — Contracting; manages Premier relationship
  - Jennifer Jordan — Demand planning
  - Len Bridgeman — Channel management team; “been dealing with shortages for 10 years”; works cross functionally
  - Jeremy How — Sales Operations; provides visibility into the post-manufacturing supply chain; works with HIRC on SRS to identify disruptions to supply chain
  - Carmel Veron — Sales
- Notes include “Intracan -follow up” (context unknown).
- “Pain control -market leader” (context unknown).
- “What resonated” section focuses on visibility into service levels and trends:
  - “We can see the service levels our customer's experience, which is the most important.”
  - “They can see their service levels to their distributors, but they can't see the distributor's service levels to their health systems.”
  - “We can see how things are trending.”
- Mentions “B. Braun Demo 5/15/23” with timestamp “Monday, May 15, 2023 10:03 AM”.

## Decisions / confirmations
- Unknown (no explicit decisions captured in this chunk).

## Open questions
- What is “Intracan” and what specifically requires follow-up?
- What does “Pain control -market leader” refer to (product/segment/company) and what is the intended takeaway?

## Action items (with owners if present)
- “Intracan -follow up” — owner unknown.

## Notable metrics/claims (exact phrases)
- “been dealing with shortages for 10 years”
- “Pain control -market leader”
- “We can see the service levels our customer's experience, which is the most important.”
- “They can see their service levels to their distributors, but they can't see the distributor's service levels to their health systems.”
- “We can see how things are trending.”
